Hospital gowns will be the new high fashion in South Burlington. It’s all part of a fundraiser through UVM's Cancer Center.

In accordance with CMS quality measures, interventions like provider/patient education and better access to care help reduce ...

An innovative solution created additional infusion chairs and decreased the risk of immuno-compromised patients visiting the ED.

Ketamine is only approved by the FDA as an anesthetic, but there is growing interest in using ketamine products to treat ...

Reducing the infusion time for nivolumab and pembrolizumab to 10 minutes is feasible and safe, according to researchers.

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

If life-threatening, stop the infusion immediately, permanently discontinue BRIUMVI, and administer appropriate supportive treatment. Less severe infusion reactions may involve temporarily stopping ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

JAMM AQUINO / JAQUINO @STARADVERTISER.COM Two checks totaling $10 million were presented Thursday at the state Capitol during a news conference announcing multimillion-dollar grants supporting cancer ...

The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares in patients with a rare immune system-related condition, the regulator said ...